The REACT-AF trial began in July 2023 and is led by researchers at Johns Hopkins Medicine. Randomized patients (half of the ...

Irvine: Johnson & Johnson MedTech has announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE Platform ...

The staff at Shasta Regional Medical Center (SRMC) is celebrating their 100th Watchman heart implant procedure, which took ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

With our offerings being available through government-compliant procurement channels, VA physicians can now prescribe Kardia devices to be delivered directly to a Veteran's door–bringing the power of ...

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug ...

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...

Dr. Mehran Attari, a cardiac electrophysiologist with Mercy Health, discusses a new treatment option for atrial fibrillation (AFib): pulse field ablation (PFA). Atrial fibrillation is the most common ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...